@article{b39f7fd923ec4997bd9331ca55ac563a,
title = "Guidelines for treating iron overload in myelodysplastic syndromes: A Taiwan consensus statement",
abstract = "Iron overload is common in myelodysplastic syndrome (MDS) patients, and an accumulation of evidence shows that iron chelation may have benefits in these patients. However, discussion and consensus about iron chelation therapy (ICT) for MDS patients is lacking in Taiwan and other Southeast Asian countries. An Expert Panel in Taiwan was organized in 2011 to develop iron overload guidelines and provide a uniform reference for physicians treating MDS patients with iron overload, with specific regard to when to initiate ICT, in which patients, and the clinical and scientific rationale behind its use.",
keywords = "Ferritin, Guidelines, ICT, Iron overload, MDS, Taiwan",
author = "Ko, {Bor Sheng} and Chang, {Cheng Shyong} and Chang, {Ming Chih} and Chen, {Tsai Yun} and Chiou, {Tzeon Jye} and Chiu, {Chang Fang} and Huang, {Wen Li} and Kao, {Woei Yau} and Lan, {Yii Jenq} and Lin, {Shen Fung} and Tan, {Tran Der} and Tang, {Jih Luh} and Tzeng, {Cheng Hwai} and Wang, {Po Nan} and Yet, {Su Pen} and Tien, {Hwei Fang}",
note = "Funding Information: T.-D. Tan Hematology and Medical Oncology, Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan Funding Information: Conflict of interest The expert panel meetings and article writing are all sponsored by the Hematology Society of Taiwan. No other potential conflicts of interest are disclosed for the authors.",
year = "2014",
month = jul,
doi = "10.1007/s12185-014-1607-x",
language = "English",
volume = "100",
pages = "7--15",
journal = "International Journal of Hematology",
issn = "0925-5710",
publisher = "Springer Japan",
number = "1",
}